🇺🇸 FDA
Company

Harmony

Harmony Biosciences Holdings

HRMY pharma USA

Quick answer

Harmony is a pharma company (HRMY) headquartered in PLYMOUTH MEETING, PA, USA with 18 tracked pipeline programs.

Pipeline (18)

project

Clemizole HCl

Dravet Syndrome

Phase 3 · small_molecule · active

1 trials project

Clemizole HCl

Lennox Gastaut Syndrome

Phase 3 · small_molecule · active

1 trials project

HBS-301 tablet

Idiopathic Hypersomnia

Phase 3 · small_molecule · active

1 trials project

Open-label pitolisant

Idiopathic Hypersomnia

Phase 3 · small_molecule · completed

1 trials project

Pitolisant

Idiopathic Hypersomnia

Phase 3 · small_molecule · completed

1 trials project

Pitolisant

Prader-Willi Syndrome

Phase 3 · small_molecule · active

1 trials project

Pitolisant tablet

Prader-Willi Syndrome

Phase 3 · small_molecule · active

1 trials project

OVX836 480µg

Influenza

Phase 2 · mab · completed

1 trials project

OVX836 shot

Vaccine-Preventable Diseases

Phase 2 · mab · completed

1 trials project

Pitolisant Oral Tablet

Myotonic Dystrophy 1

Phase 2 · small_molecule · completed

1 trials project

Pitolisant oral tablets

Prader-Willi Syndrome

Phase 2 · small_molecule · completed

1 trials project

ZYN002

22Q11.2 Deletion Syndrome

Phase 2 · small_molecule · completed

1 trials project

HBS-201

Narcolepsy

Phase 1 · small_molecule · completed

1 trials project

MV-LASV

Lassa Virus Infection

Phase 1 · mab · completed

1 trials project

Part 1

Drug Interaction

Phase 1 · small_molecule · completed

1 trials project

Pitolisant

Restless Legs Syndrome

Approved · small_molecule · active

1 trials project

Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.

Hair Thinning

Unknown · other · active

1 trials project

Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.

Hair Thinning

Unknown · other · completed

1 trials

Drugs (2)

drug

calfactant

INFASURF PRESERVATIVE FREE

 drug

pitolisant hydrochloride

WAKIX

Patents (6)

patent

US 12226373

Treatment of fragile X syndrome with cannabidiol

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12213951

Treatment of autism with cannabidiol

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12186282

Treatment of 22Q11.2 deletion syndrome with cannabidiol

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9296774

Halogenated dideoxy sugar derivates, preparation method and application thereof

Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7625575

Dermatological composition

Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 7582307

Dermatological composition

Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)